Fate Therapeutics (FATE) Other Non Operating Income (2012 - 2025)

Fate Therapeutics has reported Other Non Operating Income for 14 years, with the latest figure at $11.3 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non Operating Income rose 17.73% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (changed 0.22% YoY), and the FY2025 full-year result was $11.4 million, down 52.57% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $11.3 million, up from $2.5 million in the prior quarter.
• The five-year high for Other Non Operating Income was $26.1 million in Q4 2022, with the low at $50000.0 in Q2 2025.
• Historically, Other Non Operating Income has averaged $5.6 million across 5 years, with a median of $3.2 million in 2022.
• Annual changes were most pronounced in 2023 — Other Non Operating Income slumped 99.3% — and 2024, when it jumped 5114.67%.
• Fate Therapeutics' Other Non Operating Income stood at $761000.0 in 2021, then soared by 3336.14% to $26.1 million in 2022, then tumbled by 99.3% to $184000.0 in 2023, then jumped by 5114.67% to $9.6 million in 2024, then rose by 17.73% to $11.3 million in 2025.
• The last three Other Non Operating Income figures came in at $11.3 million (Q4 2025), $2.5 million (Q3 2025), and $50000.0 (Q2 2025), per Business Quant data.